MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
4.500
-0.250 (-5.26%)
At close: Mar 6, 2026, 4:00 PM EST
4.590
+0.090 (2.00%)
After-hours: Mar 6, 2026, 7:21 PM EST
MiMedx Group Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for MiMedx Group stock have an average target of 10, with a low estimate of 8.00 and a high estimate of 12. The average target predicts an increase of 122.22% from the current stock price of 4.50.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MiMedx Group stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 1 | 1 | 1 |
| Buy | 1 | 1 | 2 | 2 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Buy Initiates $10 | Buy | Initiates | $10 | +122.22% | Feb 23, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $12 → $8 | Buy | Maintains | $12 → $8 | +77.78% | Feb 17, 2026 |
| Lake Street | Lake Street | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +122.22% | Jan 20, 2026 |
| Mizuho | Mizuho | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +122.22% | Dec 17, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $11 → $12 | Buy | Maintains | $11 → $12 | +166.67% | Jul 31, 2025 |
Financial Forecast
Revenue This Year
354.36M
from 418.63M
Decreased by -15.35%
Revenue Next Year
400.94M
from 354.36M
Increased by 13.14%
EPS This Year
0.12
from 0.32
Decreased by -63.88%
EPS Next Year
0.24
from 0.12
Increased by 105.89%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 377.2M | 433.1M | |||
| Avg | 354.4M | 400.9M | |||
| Low | 333.2M | 365.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -9.9% | 22.2% | |||
| Avg | -15.4% | 13.1% | |||
| Low | -20.4% | 3.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 0.19 | 0.32 | |||
| Avg | 0.12 | 0.24 | |||
| Low | 0.04 | 0.15 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -40.9% | 172.5% | |||
| Avg | -63.9% | 105.9% | |||
| Low | -87.7% | 27.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.